{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:10:57Z","timestamp":1791400257561,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21905112"],"award-info":[{"award-number":["21905112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515110889"],"award-info":[{"award-number":["2021A1515110889"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515011763"],"award-info":[{"award-number":["2022A1515011763"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220530144816037"],"award-info":[{"award-number":["JCYJ20220530144816037"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.actbio.2023.03.001","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T11:35:59Z","timestamp":1678275359000},"page":"226-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Cation-free siRNA-cored nanocapsules for tumor-targeted RNAi therapy"],"prefix":"10.1016","volume":"161","author":[{"given":"Xinghua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyu","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziji","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9883-8570","authenticated-orcid":false,"given":"Shaohui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.actbio.2023.03.001_bib0001","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"Patisiran: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.actbio.2023.03.001_bib0002","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40265-020-01269-0","article-title":"Givosiran: first approval","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.actbio.2023.03.001_bib0003","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.molmed.2022.08.003","article-title":"siRNA modification and delivery for drug development","volume":"28","author":"Zhang","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.actbio.2023.03.001_bib0004","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.122.001234","article-title":"RNAi-based therapeutics and novel RNA bioengineering technologies","volume":"384","author":"Traber","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.actbio.2023.03.001_bib0005","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1021\/acs.nanolett.0c04468","article-title":"Core role of hydrophobic core of polymeric nanomicelle in endosomal escape of siRNA","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2023.03.001_bib0006","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2147\/IJN.S200253","article-title":"Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach","volume":"14","author":"Mahmoodi Chalbatani","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"41","key":"10.1016\/j.actbio.2023.03.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203823","article-title":"Unprotonatable and ROS-sensitive nanocarrier for NIR spatially activated siRNA therapy with synergistic drug effect","volume":"18","author":"Deng","year":"2022","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.actbio.2023.03.001_bib0008","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1007\/s12274-018-2116-7","article-title":"Functionalization of silica nanoparticles for nucleic acid delivery","volume":"11","author":"Kamegawa","year":"2018","journal-title":"Nano Res."},{"issue":"41","key":"10.1016\/j.actbio.2023.03.001_bib0009","doi-asserted-by":"crossref","first-page":"13582","DOI":"10.1002\/anie.201809056","article-title":"Customizable lipid nanoparticle materials for the delivery of siRNAs and mRNAs","volume":"57","author":"Fenton","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"2","key":"10.1016\/j.actbio.2023.03.001_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2010.03.019","article-title":"Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown","volume":"145","author":"Kim","year":"2010","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2023.03.001_bib0011","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.actbio.2016.12.005","article-title":"Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes","volume":"49","author":"Chen","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2023.03.001_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tiv.2016.08.002","article-title":"In vitro toxicity of cationic micelles and liposomes in cultured human hepatocyte (HepG2) and lung epithelial (A549) cell lines","volume":"36","author":"Roursgaard","year":"2016","journal-title":"Toxicol. in Vitro"},{"issue":"15","key":"10.1016\/j.actbio.2023.03.001_bib0013","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.molimm.2007.04.009","article-title":"Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines","volume":"44","author":"Yan","year":"2007","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2023.03.001_bib0014","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/09687860600790537","article-title":"Immunostimulation of dendritic cells by cationic liposomes","volume":"23","author":"Vangasseri","year":"2006","journal-title":"Mol. Membr. Biol."},{"issue":"5","key":"10.1016\/j.actbio.2023.03.001_bib0015","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/eji.200737998","article-title":"DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4","volume":"38","author":"Tanaka","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.actbio.2023.03.001_bib0016","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd4685","article-title":"Clinical experiences with systemically administered siRNA-based therapeutics in cancer","volume":"14","author":"Zuckerman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.actbio.2023.03.001_bib0017","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nano.2014.08.004","article-title":"In vivo toxicity of cationic micelles and liposomes","volume":"11","author":"Knudsen","year":"2015","journal-title":"Nanomed. Nanotechnol."},{"issue":"3","key":"10.1016\/j.actbio.2023.03.001_bib0018","article-title":"Noncationic material design for nucleic acid delivery","volume":"3","author":"Jiang","year":"2020","journal-title":"Adv. Ther. Germany"},{"issue":"11","key":"10.1016\/j.actbio.2023.03.001_bib0019","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41587-020-0725-7","article-title":"Big pharma buys into exosomes for drug delivery","volume":"38","author":"Zipkin","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.actbio.2023.03.001_bib0020","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1021\/acsnano.1c03072","article-title":"Spherical nucleic acids for near-infrared light-responsive self-delivery of small-interfering RNA and antisense oligonucleotide","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"issue":"45","key":"10.1016\/j.actbio.2023.03.001_bib0021","article-title":"Cation-free siRNA micelles as effective drug delivery platform and potent RNAi nanomedicines for glioblastoma therapy","volume":"33","author":"Jiang","year":"2021","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.actbio.2023.03.001_bib0022","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1002\/anie.201814289","article-title":"The siRNAsome: a cation-free and versatile nanostructure for siRNA and drug co-delivery","volume":"58","author":"Zheng","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"29","key":"10.1016\/j.actbio.2023.03.001_bib0023","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1039\/C9CC00175A","article-title":"DNA tetrahedron-based nanogels for siRNA delivery and gene silencing","volume":"55","author":"Xue","year":"2019","journal-title":"Chem. Commun."},{"issue":"50","key":"10.1016\/j.actbio.2023.03.001_bib0024","doi-asserted-by":"crossref","first-page":"16023","DOI":"10.1002\/anie.201709485","article-title":"Systemic delivery of Bc12-targeting siRNA by DNA nanoparticles suppresses cancer cell growth","volume":"56","author":"Rahman","year":"2017","journal-title":"Angew. Chem. Int. Edit."},{"issue":"2","key":"10.1016\/j.actbio.2023.03.001_bib0025","doi-asserted-by":"crossref","first-page":"eaav9322","DOI":"10.1126\/sciadv.aav9322","article-title":"Bottlebrush-architectured poly(ethylene glycol) as an efficient vector for RNA interference in vivo","volume":"5","author":"Wang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2023.03.001_bib0026","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.actbio.2023.03.001_bib0027","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/hum.2007.179","article-title":"Overcoming the innate immune response to small interfering RNA","volume":"19","author":"Judge","year":"2008","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.actbio.2023.03.001_bib0028","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/adma.201504288","article-title":"Fusogenic reactive oxygen species triggered charge-reversal vector for effective gene delivery","volume":"28","author":"Liu","year":"2016","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.actbio.2023.03.001_bib0029","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/smll.201303951","article-title":"Co-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapy","volume":"10","author":"Chen","year":"2014","journal-title":"Small"},{"issue":"40","key":"10.1016\/j.actbio.2023.03.001_bib0030","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1002\/anie.201103806","article-title":"Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release","volume":"50","author":"Dai","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.actbio.2023.03.001_bib0031","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41467-018-03119-w","article-title":"Polyrotaxane-based supramolecular theranostics","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.actbio.2023.03.001_bib0032","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1039\/C9BM00825J","article-title":"A pH and reduction dual-sensitive polymeric nanomicelle for tumor microenvironment triggered cellular uptake and controlled intracellular drug release","volume":"7","author":"Su","year":"2019","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2023.03.001_bib0033","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/1061186X.2011.632010","article-title":"PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor","volume":"20","author":"Kim","year":"2012","journal-title":"J. Drug Target"},{"issue":"28","key":"10.1016\/j.actbio.2023.03.001_bib0034","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1016\/j.biomaterials.2013.05.010","article-title":"Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1)","volume":"34","author":"Zeng","year":"2013","journal-title":"Biomaterials"},{"issue":"48","key":"10.1016\/j.actbio.2023.03.001_bib0035","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1002\/adma.201403877","article-title":"A reduction and pH dual-sensitive polymeric vector for long-circulating and tumor-targeted siRNA delivery","volume":"26","author":"Li","year":"2014","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.actbio.2023.03.001_bib0036","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1039\/C5CC09181K","article-title":"Construction of negatively charged and environment-sensitive nanomedicine for tumor-targeted efficient siRNA delivery","volume":"52","author":"Wang","year":"2016","journal-title":"Chem. Commun. (Camb)"},{"issue":"2","key":"10.1016\/j.actbio.2023.03.001_bib0037","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/1061186X.2018.1473409","article-title":"cRGD functionalised nanocarriers for targeted delivery of bioactives","volume":"27","author":"Gajbhiye","year":"2019","journal-title":"J. Drug Target"},{"key":"10.1016\/j.actbio.2023.03.001_bib0038","article-title":"siRNA based drug design, quality, delivery and clinical translation","volume":"29","author":"Subhan","year":"2020","journal-title":"Nanomedicine"},{"issue":"37","key":"10.1016\/j.actbio.2023.03.001_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202209227","article-title":"Thiol-disulfide exchange as a route for endosomal escape of polymeric nanoparticles","volume":"61","author":"Kanjilal","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.actbio.2023.03.001_bib0040","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1021\/acs.nanolett.9b00657","article-title":"Facile hydrophobization of siRNA with anticancer drug for non-cationic nanocarrier-mediated systemic delivery","volume":"19","author":"Xu","year":"2019","journal-title":"Nano Lett."},{"issue":"30","key":"10.1016\/j.actbio.2023.03.001_bib0041","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1002\/adfm.201501548","article-title":"Optimizing the size of Micellar nanoparticles for efficient siRNA delivery","volume":"25","author":"Liang","year":"2015","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.actbio.2023.03.001_bib0042","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/1078-0432.CCR-09-1380","article-title":"Targeting Polo-like kinase in cancer therapy","volume":"16","author":"Degenhardt","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123001290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123001290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:04:24Z","timestamp":1761674664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706123001290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"alternative-id":["S1742706123001290"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2023.03.001","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cation-free siRNA-cored nanocapsules for tumor-targeted RNAi therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2023.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}